T1	Participants 10 39	patient withdrawal on a study
T2	Participants 187 505	differential patient withdrawal from a randomized controlled trial evaluating pharmacist management of hypertension, to compare the characteristics of patients who withdrew with those of patients who completed the study, and to identify characteristics that predispose patients to withdraw from hypertension management
T3	Participants 608 641	Four hundred sixty-three patients
T4	Participants 815 908	Patients were randomly allocated to the pharmacist intervention or usual-care (control) group
T5	Participants 910 952	Those in the pharmacist intervention group
T6	Participants 1062 1091	Patients in the control group
T7	Participants 1188 1290	463 patients, 191 (41%) withdrew from the study after randomization and 272 (59%) completed the study.
T8	Participants 1291 1415	Patients who withdrew from the pharmacist intervention group were similar to patients who withdrew from the usual-care group
T9	Participants 1484 1604	Patients who smoked or had commercial insurance were more likely to withdraw from the study than the other participants.
T10	Participants 1890 1937	group patient characteristics remained balanced
T11	Participants 2088 2229	patients who withdrew versus those who completed, with the exception of insurance status, suggests that external validity was not jeopardized
